SCRC.......NEWS OUT!....More powerfull revenue numbers and increase of sales to another business operation source of ScripsAmerica Inc.!.....> July 14, 2014 - 8:30 AM EDT
Wholesale Rx, ScripsAmerica's Equity Venture, Reports Significant YoY Revenue Growth During Q2 2014
TYSONS CORNER, VA--(Marketwired - Jul 14, 2014) - ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $696,808 in orders during the quarter ended June 30, 2014 compared to $26,000 during the same quarter in 2013, prior to ScripsAmerica's involvement with the company.
ScripsAmerica entered into an equity venture with WRx, a Tennessee-based pharmaceutical distributor, during the third quarter of 2013 to provide its independent pharmacy clients with prescription drugs at competitive prices with consistent timely delivery.
ScripsAmerica's CEO, Bob Schneiderman, stated, "The Company is pleased to report significant year over year revenue growth for WRx during the second quarter. In a short time since ScripsAmerica began working with WRx and formed an equity venture with the company, its sales have grown tremendously and are on par with Scrips' overall projected revenue growth in 2014. We expect this level of sales revenue to continue from WRx and further increase in the future as they expand their pharmaceutical distribution capabilities to additional states."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Wholesale Rx, ScripsAmerica's Equity Venture, Reports Significant YoY Revenue Growth During Q2 2014
TYSONS CORNER, VA--(Marketwired - Jul 14, 2014) - ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $696,808 in orders during the quarter ended June 30, 2014 compared to $26,000 during the same quarter in 2013, prior to ScripsAmerica's involvement with the company.
ScripsAmerica entered into an equity venture with WRx, a Tennessee-based pharmaceutical distributor, during the third quarter of 2013 to provide its independent pharmacy clients with prescription drugs at competitive prices with consistent timely delivery.
ScripsAmerica's CEO, Bob Schneiderman, stated, "The Company is pleased to report significant year over year revenue growth for WRx during the second quarter. In a short time since ScripsAmerica began working with WRx and formed an equity venture with the company, its sales have grown tremendously and are on par with Scrips' overall projected revenue growth in 2014. We expect this level of sales revenue to continue from WRx and further increase in the future as they expand their pharmaceutical distribution capabilities to additional states."
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
